QS Investors’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-307
| Closed | -$107K | – | 1414 |
|
|
2020
Q2 | $107K | Hold |
307
| – | – | ﹤0.01% | 1300 |
|
|
2020
Q1 | $83K | Hold |
307
| – | – | ﹤0.01% | 1309 |
|
|
2019
Q4 | $97K | Sell |
307
-123
| -29% | -$38.9K | ﹤0.01% | 1396 |
|
|
2019
Q3 | $118K | Hold |
430
| – | – | ﹤0.01% | 1342 |
|
|
2019
Q2 | $230K | Hold |
430
| – | – | ﹤0.01% | 1185 |
|
|
2019
Q1 | $217K | Sell |
430
-1
| -0.2% | -$505 | ﹤0.01% | 1196 |
|
|
2018
Q4 | $213K | Sell |
431
-1,767
| -80% | -$873K | ﹤0.01% | 1106 |
|
|
2018
Q3 | $2.01M | Hold |
2,198
| – | – | 0.02% | 624 |
|
|
2018
Q2 | $1.61M | Buy |
2,198
+1,834
| +504% | +$1.34M | 0.02% | 657 |
|
|
2018
Q1 | $580K | Buy |
364
+123
| +51% | +$196K | 0.01% | 904 |
|
|
2017
Q4 | $216K | Buy |
241
+1
| +0.4% | +$896 | ﹤0.01% | 1176 |
|
|
2017
Q3 | $86K | Hold |
240
| – | – | ﹤0.01% | 1428 |
|
|
2017
Q2 | $70K | Sell |
240
-2
| -0.8% | -$583 | ﹤0.01% | 1450 |
|
|
2017
Q1 | $85K | Buy |
242
+240
| +12,000% | +$84.3K | ﹤0.01% | 1419 |
|
|
2016
Q4 | $1K | Hold |
2
| – | – | ﹤0.01% | 1682 |
|
|
2016
Q3 | $1K | Buy |
2
+1
| +100% | +$500 | ﹤0.01% | 1671 |
|
|
2016
Q2 | $1K | Buy |
+1
| New | +$1K | ﹤0.01% | 1714 |
|
|
2016
Q1 | – | Sell |
-2,219
| Closed | -$561K | – | 2029 |
|
|
2015
Q4 | $561K | Buy |
2,219
+1
| +0% | +$253 | 0.01% | 884 |
|
|
2015
Q3 | $365K | Sell |
2,218
-19
| -0.8% | -$3.13K | ﹤0.01% | 948 |
|
|
2015
Q2 | $420K | Hold |
2,237
| – | – | 0.01% | 909 |
|
|
2015
Q1 | $370K | Buy |
2,237
+19
| +0.9% | +$3.14K | ﹤0.01% | 936 |
|
|
2014
Q4 | $516K | Buy |
+2,218
| New | +$516K | 0.01% | 850 |
|